Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

African American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patients.

Mitchell SG, Kelly SM, Gryczynski J, Myers CP, Jaffe JH, O'Grady KE, Olsen YK, Schwartz RP.

Drug Alcohol Depend. 2012 Apr 1;122(1-2):55-60. doi: 10.1016/j.drugalcdep.2011.09.009.

2.

Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.

Gryczynski J, Jaffe JH, Schwartz RP, Dušek KA, Gugsa N, Monroe CL, O'Grady KE, Olsen YK, Mitchell SG.

Am J Addict. 2013 May-Jun;22(3):285-91. doi: 10.1111/j.1521-0391.2012.12004.x.

3.

A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.

Kelly SM, Brown BS, Katz EC, O'Grady KE, Mitchell SG, King S, Schwartz RP.

Am J Drug Alcohol Abuse. 2012 May;38(3):233-8. doi: 10.3109/00952990.2011.643983.

4.

Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O'Grady KE, Jaffe JH.

J Addict Dis. 2015;34(2-3):151-61. doi: 10.1080/10550887.2015.1059222.

5.

Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.

Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL.

J Subst Abuse Treat. 2015 Jul;54:29-36. doi: 10.1016/j.jsat.2015.01.014.

6.

Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.

Awgu E, Magura S, Rosenblum A.

J Psychoactive Drugs. 2010 Sep;42(3):339-46.

7.

Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.

Maas J, Barton G, Maskrey V, Pinto H, Holland R.

Drug Alcohol Depend. 2013 Dec 1;133(2):494-501. doi: 10.1016/j.drugalcdep.2013.07.018.

PMID:
23962419
8.

Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.

Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.

J Subst Abuse Treat. 2006 Jul;31(1):3-7. Review.

PMID:
16814005
9.

Quality of life among heroin users on buprenorphine versus methadone maintenance.

Ponizovsky AM, Grinshpoon A.

Am J Drug Alcohol Abuse. 2007;33(5):631-42.

PMID:
17891656
10.

Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy.

Pajusco B, Chiamulera C, Quaglio G, Moro L, Casari R, Amen G, Faccini M, Lugoboni F.

Int J Environ Res Public Health. 2012 Mar;9(3):932-42. doi: 10.3390/ijerph9030932.

11.

Retention in methadone and buprenorphine treatment among African Americans.

Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O'Grady KE, Olsen YK, Schwartz RP.

J Subst Abuse Treat. 2013 Sep;45(3):287-92. doi: 10.1016/j.jsat.2013.02.008.

12.

Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.

Piralishvili G, Otiashvili D, Sikharulidze Z, Kamkamidze G, Poole S, Woody GE.

J Subst Abuse Treat. 2015 Mar;50:32-7. doi: 10.1016/j.jsat.2014.10.003.

PMID:
25456093
13.

[Reimbursement of opiate substitution drugs to militaries in 2007].

d'Argouges F, Desjeux G, Marsan P, Thevenin-Garron V.

Encephale. 2012 Sep;38(4):304-9. doi: 10.1016/j.encep.2011.11.010. French.

PMID:
22980471
14.

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.

Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.

Drug Alcohol Depend. 2003 Apr 1;69(3):263-72.

PMID:
12633912
15.

The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).

Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R.

Drug Alcohol Rev. 2005 Sep;24(5):411-8.

PMID:
16298835
16.

[Characteristics of heroin dependent patients admitted to a methadone treatment program].

Sanvisens A, Rivas I, Faure E, Muñoz T, Rubio M, Fuster D, Tor J, Muga R.

Med Clin (Barc). 2014 Jan 21;142(2):53-8. doi: 10.1016/j.medcli.2012.10.023. Spanish.

PMID:
23337454
17.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
18.

Outcome of heroin-dependent adolescents presenting for opiate substitution treatment.

Smyth BP, Fagan J, Kernan K.

J Subst Abuse Treat. 2012 Jan;42(1):35-44. doi: 10.1016/j.jsat.2011.07.007.

PMID:
21940134
19.

Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment.

Quaglio G, Lugoboni F, Pattaro C, Melara B; G.I.C.S., Mezzelani P, Des Jarlais DC; G.I.C.S..

Drug Alcohol Depend. 2008 Apr 1;94(1-3):12-8.

PMID:
18083312
20.

Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.

Ayres R, Ingram J, Rees A, Neale J, Beattie A, Telfer M.

Subst Abuse Treat Prev Policy. 2014 Nov 18;9:44. doi: 10.1186/1747-597X-9-44.

Supplemental Content

Support Center